These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 19149853

  • 1. Clinical benefit of recombinant factor VIIa in management of bleeds and surgery in two brothers suffering from the Bernard-Soulier syndrome.
    Tefre KL, Ingerslev J, Sørensen B.
    Haemophilia; 2009 Jan; 15(1):281-4. PubMed ID: 19149853
    [Abstract] [Full Text] [Related]

  • 2. Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome.
    Ozelo MC, Svirin P, Larina L.
    Ann Hematol; 2005 Nov; 84(12):816-22. PubMed ID: 16044315
    [Abstract] [Full Text] [Related]

  • 3. Treatment of inherited platelet disorders.
    Seligsohn U.
    Haemophilia; 2012 Jul; 18 Suppl 4():161-5. PubMed ID: 22726101
    [Abstract] [Full Text] [Related]

  • 4. [Obstetric and gynecological intervention in women with Bernard-Soulier syndrome: report of two cases].
    Mitrović M, Elezović I, Miljić P, Antić D.
    Srp Arh Celok Lek; 2014 Jul; 142(5-6):351-5. PubMed ID: 25033594
    [Abstract] [Full Text] [Related]

  • 5. Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency.
    O'Connell NM, Riddell AF, Pascoe G, Perry DJ, Lee CA.
    Haemophilia; 2008 Jul; 14(4):775-81. PubMed ID: 18384352
    [Abstract] [Full Text] [Related]

  • 6. Treatment of bleeding in patients with platelet disorders: is there a place for recombinant factor VIIa?
    Laurian Y.
    Pathophysiol Haemost Thromb; 2002 Jul; 32 Suppl 1():37-40. PubMed ID: 12214146
    [Abstract] [Full Text] [Related]

  • 7. The use of recombinant factor VIIa in children with inherited platelet function disorders.
    Almeida AM, Khair K, Hann I, Liesner R.
    Br J Haematol; 2003 May; 121(3):477-81. PubMed ID: 12716372
    [Abstract] [Full Text] [Related]

  • 8. Congenital and acquired platelet disorders: current dilemmas and treatment strategies.
    White GC.
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S37-41. PubMed ID: 16427384
    [Abstract] [Full Text] [Related]

  • 9. Clinical phenotype in heterozygote and biallelic Bernard-Soulier syndrome--a case control study.
    Bragadottir G, Birgisdottir ER, Gudmundsdottir BR, Hilmarsdottir B, Vidarsson B, Magnusson MK, Larsen OH, Sorensen B, Ingerslev J, Onundarson PT.
    Am J Hematol; 2015 Feb; 90(2):149-55. PubMed ID: 25370924
    [Abstract] [Full Text] [Related]

  • 10. Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa.
    Peters M, Heijboer H.
    Thromb Haemost; 1998 Aug; 80(2):352. PubMed ID: 9716174
    [No Abstract] [Full Text] [Related]

  • 11. Complementary effect of fibrinogen and rFVIIa on clotting ex vivo in Bernard-Soulier syndrome and combined use during three deliveries.
    Palsson R, Vidarsson B, Gudmundsdottir BR, Larsen OH, Ingerslev J, Sorensen B, Onundarson PT.
    Platelets; 2014 Aug; 25(5):357-62. PubMed ID: 23909788
    [Abstract] [Full Text] [Related]

  • 12. Management of factor VII-deficient patients undergoing joint surgeries--preliminary results of locally developed treatment regimen.
    Windyga J, Zbikowski P, Ambroziak P, Baran B, Kotela I, Stefanska-Windyga E.
    Haemophilia; 2013 Jan; 19(1):89-93. PubMed ID: 22845882
    [Abstract] [Full Text] [Related]

  • 13. [Recombinant factor VIIa in patients with platelet function disorders or thrombocytopenia].
    Zotz RB, Scharf RE.
    Hamostaseologie; 2007 Sep; 27(4):251-62. PubMed ID: 17938763
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
    Manning BJ, Hynes N, Courtney DF, Sultan S.
    Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):525-7. PubMed ID: 16099693
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group.
    Poon MC, d'Oiron R.
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S55-68. PubMed ID: 10850567
    [Abstract] [Full Text] [Related]

  • 18. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
    Hennewig U, Laws HJ, Eisert S, Göbel U.
    Klin Padiatr; 2005 Apr; 217(6):365-70. PubMed ID: 16307424
    [Abstract] [Full Text] [Related]

  • 19. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U, Erhardtsen E.
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [Abstract] [Full Text] [Related]

  • 20. Iron deficiency anemia and bleeding management in pediatric patients with Bernard-Soulier syndrome and Glanzmann Thrombasthenia: A single-institution analysis.
    Lee A, Maier CL, Batsuli G.
    Haemophilia; 2022 Jul; 28(4):633-641. PubMed ID: 35412688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.